Skip to main content
Figure 1 | BMC Infectious Diseases

Figure 1

From: Utility of CD4 cell counts for early prediction of virological failure during antiretroviral therapy in a resource-limited setting

Figure 1

(A) Kaplan-Meier probabilities of virologic failure-free proportion. The numbers of patients followed up for 0, 12, 24, 36, 48 and 60 months were 330, 180, 123, 82, 39 and 26, respectively. (B) Kaplan-Meier probabilities of failure-free survival stratified by baseline CD4 cell count quartile range (median = 327; IQR = 205–435 cells/ul).

Back to article page